2001
DOI: 10.1001/archinte.161.5.767
|View full text |Cite
|
Sign up to set email alerts
|

Intranasal Tranexamic Acid Treatment for Severe Epistaxis in Hereditary Hemorrhagic Telangiectasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
24
0
5

Year Published

2009
2009
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(29 citation statements)
references
References 4 publications
0
24
0
5
Order By: Relevance
“…Corresponding values in the study of Tibbelin et al are 11% and 31%. Klepfish et al [13] reported a marked decline in the intensity of epistaxis controlling within minutes after using tranexamic acid in a patient with hereditary hemorrhagic telangiectasia, and after years, he almost stopped using iron supplement and blood transfusions almost concomitantly. Sabba et al [7] reported an improvement in treating 3 cases of intractable epistaxis in patients with hereditary hemorrhagic telangiectasia with high doses of tranexamic acid administered orally.…”
Section: Discussionmentioning
confidence: 99%
“…Corresponding values in the study of Tibbelin et al are 11% and 31%. Klepfish et al [13] reported a marked decline in the intensity of epistaxis controlling within minutes after using tranexamic acid in a patient with hereditary hemorrhagic telangiectasia, and after years, he almost stopped using iron supplement and blood transfusions almost concomitantly. Sabba et al [7] reported an improvement in treating 3 cases of intractable epistaxis in patients with hereditary hemorrhagic telangiectasia with high doses of tranexamic acid administered orally.…”
Section: Discussionmentioning
confidence: 99%
“…Of particular interest is the increasing use of tranexamic acid by oral surgeons in the form of mouthwash for dental extractions [7,8] and in the management of epistaxis with hereditary hemorrhagic telangiectasia [9,10]. Only two studies have reported the efficacy of topical [11] and oral [12] forms of tranexamic acid in achieving hemostasis and improving the surgical field in nasal surgeries, including FESS.…”
Section: Introductionmentioning
confidence: 99%
“…Для этих целей ис пользуются различные группы медикаментов: лу бриканты (физиологический раствор, мази с анти биотиками), мази/кремы с гормональными препара тами, антифибринолитики [57][58][59][60]. Хирургическое лечение включает лазерные, химические и электри ческие методы эндоназальной коагуляции, дермо пластику перегородки носа (пересадка кожи или буккальной слизистой), эмболизацию носовой арте рии и закрытие носовой полости (операция Янга) [57,[61][62][63][64][65][66].…”
Section: лечениеunclassified